Skip to main content
TipRanks
Go Ultimate75% OFF

Valeo Pharma (VPHIF) Q2 2020 Earnings Report

14 Followers

VPHIF Q2 2020 EPS Results

Actual EPS
-$0.01
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
-$0.02

VPHIF Q2 2020 Revenue Results

Actual Revenue
$1.45M
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
+106.04%

Earnings Announcement Details

Quarter
Q2 2020
Date
07/02/2020
Time
Before Open
Conference Call
Thursday, July 2, 2020

Q2 2020 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2020 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2020 Earnings Call Summary

No earnings call summary is available for this earnings event.

VPHIF Earnings History

VPHIF earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Sep 10, 20252025 (Q3)―--0.06―
Jun 17, 20252025 (Q2)―--0.06―
Mar 27, 20252025 (Q1)―--0.06―
Feb 26, 20252024 (Q4)―-――
Sep 12, 20242024 (Q3)-0.03-0.06-0.05-18.57% (-0.01)
Jun 13, 20242024 (Q2)-0.03-0.06-0.060.00% (+0.00)
Mar 14, 20242024 (Q1)-0.05-0.06-0.060.00% (+0.00)
Jan 29, 20242023 (Q4)-0.04-0.07-0.089.09% (+0.01)
Sep 13, 20232023 (Q3)-0.04-0.05-0.04-16.67% (-0.01)
Jun 13, 20232023 (Q2)-0.05-0.06-0.04-33.33% (-0.01)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed